The Precision Drilling Co. (PD) PT Set at C$7.00 by Scotiabank

The Precision Drilling Co. (PD) PT Set at C$7.00 by Scotiabank

Precision Drilling Co. (TSE:PD) has been assigned a C$7.00 price objective by research analysts at Scotiabank in a report issued on Tuesday. The firm presently has a a “speculative buy” rating on the stock. Scotiabank’s price objective points to a potential upside of 18.24% from the company’s current price. Several other equities research analysts have also recently issued reports on PD. TD Securities reiterated a “buy” rating and issued a C$8.00 price objective on shares of Precision Drilling in a report on Tuesday, November 8th. Deutsche Bank AG lifted their…

The Calithera Biosciences Inc. (CALA) Rating Increased to Buy at Zacks Investment Research

The Calithera Biosciences Inc. (CALA) Rating Increased to Buy at Zacks Investment Research

Calithera Biosciences Inc. (NASDAQ:CALA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Monday. The firm currently has a $3.75 price objective on the stock. Zacks Investment Research’s price target would suggest a potential upside of 19.05% from the company’s current price. According to Zacks, “Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company. It is focused on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. The Company’s…

The American Farmland Co (AFCO) Upgrade to “Buy” by Zacks Investment Research

The American Farmland Co (AFCO) Upgrade to “Buy” by Zacks Investment Research

Zacks Investment Research upgraded shares of American Farmland Co (NASDAQ:AFCO) from a hold rating to a buy rating in a research report released on Monday morning. They currently have $8.25 target price on the stock. According to Zacks, “American Farmland Company is a real estate investment trust which focused on the ownership, acquisition, development and management of farmland. Its operating segment consists of Permanent Crop, Specialty/Vegetable Row Crop, Commodity Row Crop and Development. Permanent Crop Segment which produces fruits and tree nuts; Specialty/Vegetable Row Crop Segment, which provides vegetable products;…

The Blueprint Medicines Corp. (BPMC) Rating Increased to Buy at Zacks Investment Research

The Blueprint Medicines Corp. (BPMC) Rating Increased to Buy at Zacks Investment Research

Blueprint Medicines Corp. (NASDAQ:BPMC) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Monday. The brokerage currently has a $39.00 price objective on the stock. Zacks Investment Research’s target price suggests a potential upside of 11.43% from the company’s previous close. According to Zacks, “Blueprint Medicines Corp is an oncology company which is engaged in developing kinase inhibitors for genomically defined cancer subsets. Blueprint Medicines Corp is based in Cambridge, MA. “ Other research analysts also recently issued research reports…

The Advisors Asset Management Inc. invests in OGE Energy Corp. (OGE) Shares

The Advisors Asset Management Inc. invests in OGE Energy Corp. (OGE) Shares

Advisors Asset Management Inc. increased its stake in shares of OGE Energy Corp. (NYSE:OGE) by 8.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 66,098 shares of the company’s stock after buying an additional 5,033 shares during the period. Advisors Asset Management Inc.’s holdings in OGE Energy Corp. were worth $2,090,000 at the end of the most recent reporting period. Other large investors also recently made changes to their positions in the company. Assetmark Inc. bought a…

The Advisors Asset Management Inc. invests in 2,354 by purchasing Avery Dennison Corp. (AVY) shares

The Advisors Asset Management Inc. invests in 2,354 by purchasing Avery Dennison Corp. (AVY) shares

Advisors Asset Management Inc. increased its stake in Avery Dennison Corp. (NYSE:AVY) by 9.1% during the third quarter, Holdings Channel reports. The firm owned 28,194 shares of the company’s stock after buying an additional 2,354 shares during the period. Advisors Asset Management Inc.’s holdings in Avery Dennison Corp. were worth $2,193,000 as of its most recent SEC filing. A number of other institutional investors also recently added to or reduced their stakes in AVY. Chevy Chase Trust Holdings Inc. raised its position in Avery Dennison Corp. by 0.9% in the…

The Tocqueville Asset Management L.P. Sold shares of McKesson Corp. (MCK)

The Tocqueville Asset Management L.P. Sold shares of McKesson Corp. (MCK)

Tocqueville Asset Management L.P. cut its position in McKesson Corp. (NYSE:MCK) by 10.9% during the third quarter, Holdings Channel reports. The firm owned 3,695 shares of the company’s stock after selling 450 shares during the period. Tocqueville Asset Management L.P.’s holdings in McKesson Corp. were worth $616,000 at the end of the most recent quarter. Several other institutional investors also recently made changes to their positions in the company. Skandinaviska Enskilda Banken AB publ boosted its position in shares of McKesson Corp. by 0.3% in the second quarter. Skandinaviska Enskilda…

The 8,419 Shares of Nippon Telegraph & Telephone Corp. (NTT) are sold by Advisors Asset Management Inc.

The 8,419 Shares of Nippon Telegraph & Telephone Corp. (NTT) are sold by Advisors Asset Management Inc.

Advisors Asset Management Inc. lowered its position in Nippon Telegraph & Telephone Corp. (NYSE:NTT) by 16.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 42,826 shares of the company’s stock after selling 8,419 shares during the period. Advisors Asset Management Inc.’s holdings in Nippon Telegraph & Telephone Corp. were worth $1,962,000 as of its most recent SEC filing. Other large investors have also recently modified their holdings of the company. Bank of Montreal Can bought a new stake in…

The Cooper-Standard Holdings Inc. (CPS) Upgrade by Zacks Investment Research to Buy

The Cooper-Standard Holdings Inc. (CPS) Upgrade by Zacks Investment Research to Buy

Zacks Investment Research upgraded shares of Cooper-Standard Holdings Inc. (NYSE:CPS) from a hold rating to a buy rating in a research note issued to investors on Monday morning. Zacks Investment Research currently has $99.00 target price on the stock. According to Zacks, “Cooper-Standard Holdings Inc. operates as a supplier of systems and components for the automotive industry. Its products include sealing and trim, fuel and brake delivery, fluid transfer, thermal and emissions and anti-vibration systems. The company markets its products directly to automotive original equipment manufacturers, tier I and tier…

The ConocoPhillips (COP) Given New $46.00 Price Target at Jefferies Group

The ConocoPhillips (COP) Given New $46.00 Price Target at Jefferies Group

ConocoPhillips (NYSE:COP) had its target price hoisted by Jefferies Group to $46.00 in a report published on Monday morning. The brokerage currently has a hold rating on the stock. Other equities research analysts have also issued research reports about the stock. Vetr lowered shares of ConocoPhillips from a hold rating to a sell rating and set a $40.39 price objective for the company. in a research note on Thursday, September 8th. Royal Bank Of Canada increased their price objective on shares of ConocoPhillips from $52.00 to $53.00 and gave the…

The Green Dot Corp. (GDOT) Lowered by Zacks Investment Research to Sell

The Green Dot Corp. (GDOT) Lowered by Zacks Investment Research to Sell

Zacks Investment Research downgraded shares of Green Dot Corp. (NYSE:GDOT) from a hold rating to a sell rating in a research note published on Monday morning. According to Zacks, “Green Dot Corporation is a technology-centric, pro-consumer Bank Holding Company with a mission to reinvent personal banking for the masses. The company is the largest provider of prepaid debit card products and prepaid card reloading services in the United States, as well as a leader in mobile banking with its GoBank mobile bank account offering. Green Dot Corporation products are available…

The HCA Holdings Inc. (HCA) Upgrade by Zacks Investment Research to “Buy”

The HCA Holdings Inc. (HCA) Upgrade by Zacks Investment Research to “Buy”

Zacks Investment Research upgraded shares of HCA Holdings Inc. (NYSE:HCA) from a hold rating to a buy rating in a report published on Monday morning. The firm currently has $81.00 price objective on the stock. According to Zacks, “HCA Inc. is a non-governmental hospital in the U.S. providing health care and related services. The Company operates a network of acute care hospitals, outpatient facilities, clinics and other patient care delivery settings. The Company also owns and manages freestanding surgery centers, diagnostic and imaging centers, radiation and oncology therapy centers, rehabilitation…

The CalAtlantic Group Inc. (CAA) Now Covered by Analysts at Evercore ISI

The CalAtlantic Group Inc. (CAA) Now Covered by Analysts at Evercore ISI

Evercore ISI initiated coverage on shares of CalAtlantic Group Inc. (NYSE:CAA) in a research note issued to investors on Monday. The brokerage issued a buy rating on the stock. A number of other analysts have also commented on the company. Zacks Investment Research lowered CalAtlantic Group from a hold rating to a sell rating in a report on Tuesday, October 11th. Wells Fargo & Co. began coverage on CalAtlantic Group in a report on Wednesday, September 28th. They issued a market perform rating for the company. FBR & Co reissued…

The Advisors Asset Management Inc. Buys 2,228 Shares of Constellation Brands Inc. (STZ)

The Advisors Asset Management Inc. Buys 2,228 Shares of Constellation Brands Inc. (STZ)

Advisors Asset Management Inc. boosted its stake in Constellation Brands Inc. (NYSE:STZ) by 23.4% during the third quarter, Holdings Channel reports. The firm owned 11,762 shares of the company’s stock after buying an additional 2,228 shares during the period. Advisors Asset Management Inc.’s holdings in Constellation Brands were worth $1,958,000 at the end of the most recent quarter. Other large investors have also recently made changes to their positions in the company. First Republic Investment Management Inc. raised its stake in shares of Constellation Brands by 25.6% in the first…

The Gentex Corp. (GNTX) Decreased to “Hold” at Zacks Investment Research

The Gentex Corp. (GNTX) Decreased to “Hold” at Zacks Investment Research

Zacks Investment Research lowered shares of Gentex Corp. (NASDAQ:GNTX) from a buy rating to a hold rating in a report published on Monday morning. According to Zacks, “Gentex Corporation is an international company that provides high-quality products to the worldwide automotive industry and North American fire protection market. The Company develops, manufactures and markets proprietary electro-optic products, including interior and exterior electrochromic, automatic-dimming Night Vision Safety automotive rearview mirrors that dim in proportion to the amount of headlight glare from trailing vehicle headlamps, and an extensive line of fire protection…

The Global Blood Therapeutics Inc. (GBT) gets Sell status at Zacks Investment Research

The Global Blood Therapeutics Inc. (GBT) gets Sell status at Zacks Investment Research

Zacks Investment Research cut shares of Global Blood Therapeutics Inc. (NASDAQ:GBT) from a buy rating to a sell rating in a research report report published on Monday. According to Zacks, “Global Blood Therapeutics, Inc. is a biopharmaceutical company which is engaged in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Its product candidate consists of GBT440 is an oral, once-daily prophylactic therapy for sickle cell disease which is in clinical trial. The company in addition to GBT is involved in research and development activities targeted hypoxemic pulmonary…

The Flex Pharma Inc. (FLKS) Lowered by Zacks Investment Research to Hold

The Flex Pharma Inc. (FLKS) Lowered by Zacks Investment Research to Hold

Zacks Investment Research lowered shares of Flex Pharma Inc. (NASDAQ:FLKS) from a buy rating to a hold rating in a report issued on Monday. According to Zacks, “Flex Pharma, Inc. is a biotechnology company. The Company is involved in developing treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions. Flex Pharma, Inc. is headquartered in Boston, Massachusetts. “ A number of other brokerages have also recently commented on FLKS. Piper Jaffray Cos. reiterated a buy rating and issued a $25.00 target price on shares of Flex Pharma…

The First Bancorp (FBNC) Lowered by Gabelli to “Hold”

The First Bancorp (FBNC) Lowered by Gabelli to “Hold”

Gabelli cut shares of First Bancorp (NASDAQ:FBNC) from a buy rating to a hold rating in a report published on Monday morning. Several other research analysts have also commented on the company. Keefe, Bruyette & Woods raised First Bancorp from a market perform rating to an outperform rating and boosted their price target for the stock from $22.00 to $24.00 in a research report on Tuesday, August 23rd. Zacks Investment Research raised First Bancorp from a sell rating to a hold rating in a research report on Monday, October 10th….

The Encore Capital Group Inc. (ECPG) Decreased to Strong Sell at Zacks Investment Research

The Encore Capital Group Inc. (ECPG) Decreased to Strong Sell at Zacks Investment Research

Zacks Investment Research downgraded shares of Encore Capital Group Inc. (NASDAQ:ECPG) from a hold rating to a strong sell rating in a research report released on Monday. According to Zacks, “Encore Capital Group is a leading provider of debt management and recovery solutions for consumers and property owners across a broad range of assets. Through its subsidiaries, the company purchases portfolios of consumer receivables from major banks, credit unions, and utility providers, and partners with individuals as they repay their obligations and work toward financial recovery. Through its Propel Financial…

The CymaBay Therapeutics Inc. (CBAY) Stock Rating Upgrade by Zacks Investment Research

The CymaBay Therapeutics Inc. (CBAY) Stock Rating Upgrade by Zacks Investment Research

CymaBay Therapeutics Inc. (NASDAQ:CBAY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Monday. The firm presently has a $2.00 target price on the biopharmaceutical company’s stock. Zacks Investment Research’s target price points to a potential upside of 6.08% from the company’s current price. According to Zacks, “CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company’s lead product candidate, arhalofenate, is being developed for…

The Coherent Inc. (COHR) Stock Rating Reaffirm by Needham & Company LLC

The Coherent Inc. (COHR) Stock Rating Reaffirm by Needham & Company LLC

Coherent Inc. (NASDAQ:COHR)‘s stock had its “buy” rating reiterated by analysts at Needham & Company LLC in a report issued on Monday. They currently have a $145.00 price target on the stock, up from their previous price target of $130.00. Needham & Company LLC’s target price points to a potential upside of 14.79% from the company’s current price. Other analysts have also issued research reports about the company. Benchmark Co. dropped their price objective on Coherent from $115.00 to $112.00 and set a “buy” rating for the company in a…

The Vision-Sciences Inc. (CGNT) Rating Increased to Strong-Buy at Zacks Investment Research

The Vision-Sciences Inc. (CGNT) Rating Increased to Strong-Buy at Zacks Investment Research

Vision-Sciences Inc. (NASDAQ:CGNT) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Monday. The firm presently has a $2.75 target price on the medical device company’s stock. Zacks Investment Research’s target price would suggest a potential upside of 15.06% from the company’s current price. According to Zacks, “Cogentix Medical, Inc. is a medical device company which designs, develops, manufactures and markets proprietary technologies serving the urology market. The company’s primary product consists of Urgent(R) PC Neuromodulation System…

The Aduro Biotech Inc. (ADRO) Given “Outperform” Rating at FBR & Co

The Aduro Biotech Inc. (ADRO) Given “Outperform” Rating at FBR & Co

FBR & Co reaffirmed their outperform rating on shares of Aduro Biotech Inc. (NASDAQ:ADRO) in a research report report published on Monday. The firm currently has a $20.00 price objective on the stock. Other research analysts also recently issued research reports about the stock. Roth Capital restated a buy rating and issued a $20.00 price target (down previously from $22.00) on shares of Aduro Biotech in a research report on Thursday, October 27th. Canaccord Genuity set a $30.00 price target on shares of Aduro Biotech and gave the stock a…

The Zacks Investment Research Upgraded Athersys Inc. (ATHX) to Strong-Buy

The Zacks Investment Research Upgraded Athersys Inc. (ATHX) to Strong-Buy

Athersys Inc. (NASDAQ:ATHX) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research report issued on Monday. The brokerage presently has a $2.00 target price on the biopharmaceutical company’s stock. Zacks Investment Research’s price objective points to a potential upside of 16.96% from the company’s previous close. According to Zacks, “Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The company’s lead product candidate, ATHX-105, is an…

The Zacks Investment Research Downgrade Arconic (ARNC) to Strong Sell

The Zacks Investment Research Downgrade Arconic (ARNC) to Strong Sell

Arconic (NASDAQ:ARNC) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a report issued on Monday. According to Zacks, “Alcoa Inc. is the world’s leading producer and manager of primary aluminum, fabricated aluminum and alumina facilities, and is active in all major aspects of the industry. Alcoa serves the aerospace, automotive, packaging, building and construction, commercial transportation and industrial markets, bringing design, engineering, production and other capabilities of Alcoa’s businesses to customers. In addition to aluminum products and components, Alcoa also markets consumer…

The Amerigo Resources Com Npv (ARREF) Lowered by Zacks Investment Research to Sell

The Amerigo Resources Com Npv (ARREF) Lowered by Zacks Investment Research to Sell

Zacks Investment Research cut shares of Amerigo Resources Com Npv (NASDAQ:ARREF) from a hold rating to a sell rating in a research note issued to investors on Monday morning. According to Zacks, “Amerigo Resources Ltd., through its subsidiary, is engaged in producing and selling copper and molybdenum concentrates primarily in Chile. Amerigo Resources Ltd. is headquartered in Vancouver, Canada. “ Amerigo Resources Com Npv (NASDAQ:ARREF) traded down 1.6649% during trading on Monday, hitting $0.1831. The stock had a trading volume of 39,000 shares. The stock’s 50 day moving average price…

The Zacks Investment Research Downgrade Ares Capital Corp. (ARCC) to Hold

The Zacks Investment Research Downgrade Ares Capital Corp. (ARCC) to Hold

Ares Capital Corp. (NASDAQ:ARCC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Monday. According to Zacks, “ARES CAPITAL CORPORATION is a specialty finance company that is a closed-end, non-diversified management investment company. Ares Capital Corporation has elected to be regulated as a business development company under the Investment Company Act of 1940. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. Ares Capital Corporation invests primarily in first and second lien…

The African Barrick Gold Ltd (ABGLF) gets Hold status at Zacks Investment Research

The African Barrick Gold Ltd (ABGLF) gets Hold status at Zacks Investment Research

Zacks Investment Research lowered shares of African Barrick Gold Ltd (NASDAQ:ABGLF) from a buy rating to a hold rating in a research note issued to investors on Monday morning. According to Zacks, “Acacia Mining plc is a mining company which acquires and explores primarily for gold. The Company’s producing mines consists of Bulyanhulu, Buzwagi and North Mara and a portfolio of exploration projects in Tanzania, Kenya and Burkina Faso. Acacia Mining plc, formerly known as African Barrick Gold plc, is based in London, United Kingdom. “ Shares of African Barrick…

The ADOCIA SPON ADR REPR 1 (ADOCY) gets Hold status at Zacks Investment Research

The ADOCIA SPON ADR REPR 1 (ADOCY) gets Hold status at Zacks Investment Research

Zacks Investment Research cut shares of ADOCIA SPON ADR REPR 1 (NASDAQ:ADOCY) from a buy rating to a hold rating in a research report report published on Monday. According to Zacks, “Adocia SAS is a biotechnology company which is engaged in the development of insulin therapy. The Company develops a BioChaperone platform used for therapeutic protein delivery in regenerative medicine and chronic disease. Adocia SAS is based in Lyon, France. “ Shares of ADOCIA SPON ADR REPR 1 (NASDAQ:ADOCY) remained flat at $55.30 during midday trading on Monday. The company’s…

The 13,300 Shares of Advance Auto Parts Inc. (AAP) are sold by APG Asset Management N.V.

The 13,300 Shares of Advance Auto Parts Inc. (AAP) are sold by APG Asset Management N.V.

APG Asset Management N.V. cut its stake in shares of Advance Auto Parts Inc. (NYSE:AAP) by 10.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 116,896 shares of the company’s stock after selling 13,300 shares during the period. APG Asset Management N.V. owned approximately 0.16% of Advance Auto Parts worth $17,432,000 as of its most recent SEC filing. Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in…

The 154 Shares of Ventas Inc. (VTR) are sold by Tocqueville Asset Management L.P.

The 154 Shares of Ventas Inc. (VTR) are sold by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. lowered its stake in Ventas Inc. (NYSE:VTR) by 1.6% during the third quarter, Holdings Channel reports. The institutional investor owned 9,553 shares of the real estate investment trust’s stock after selling 154 shares during the period. Tocqueville Asset Management L.P.’s holdings in Ventas were worth $675,000 at the end of the most recent quarter. Several other hedge funds and other institutional investors also recently modified their holdings of VTR. Retirement Systems of Alabama boosted its position in shares of Ventas by 1.4% in the second quarter….

The APG Asset Management N.V. Maintains Stake in Kansas City Southern (KSU)

The APG Asset Management N.V. Maintains Stake in Kansas City Southern (KSU)

APG Asset Management N.V. maintained its position in Kansas City Southern (NYSE:KSU) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 194,413 shares of the company’s stock at the end of the third quarter. APG Asset Management N.V. owned approximately 0.18% of Kansas City Southern worth $18,143,000 as of its most recent filing with the SEC. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Seven Bridges Advisors LLC raised its…

The APG Asset Management N.V. reduces its investment in Yamana Gold Inc. (AUY)

The APG Asset Management N.V. reduces its investment in Yamana Gold Inc. (AUY)

APG Asset Management N.V. reduced its stake in Yamana Gold Inc. (NYSE:AUY) (TSE:YRI) by 56.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,268,776 shares of the company’s stock after selling 4,279,800 shares during the period. APG Asset Management N.V. owned 0.35% of Yamana Gold worth $18,469,000 at the end of the most recent reporting period. Several other institutional investors have also bought and sold shares of the company. Rational Advisors LLC acquired a new position in Yamana…

The Athersys Inc. (ATHX) Upgrade to Strong-Buy at Zacks Investment Research

The Athersys Inc. (ATHX) Upgrade to Strong-Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Athersys Inc. (NASDAQ:ATHX) from a hold rating to a strong-buy rating in a research note published on Monday. The firm currently has $2.00 price target on the biopharmaceutical company’s stock. According to Zacks, “Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The company’s lead product candidate, ATHX-105, is an oral, selective 5HT2c receptor agonist in Phase I clinical trials for the treatment of obesity. The company is…

The Zacks Investment Research lowers the Stock rating of Blue Buffalo Pet Products Inc. (BUFF)

The Zacks Investment Research lowers the Stock rating of Blue Buffalo Pet Products Inc. (BUFF)

Blue Buffalo Pet Products Inc. (NASDAQ:BUFF) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Monday. According to Zacks, “Blue Buffalo Pet Products, Inc. develops, produces, markets and sells pet food primarily in the United States. The Company’s product lines include BLUE Life Protection Formula, BLUE Wilderness, BLUE Basics, BLUE Freedom and BLUE Naturally Fresh line. It offers dry foods, wet foods as well as treats for puppies, adult dogs, senior dogs and litters for kittens, adult cats…

The Manulife Financial Corp. (MFC) Receives Outperform Rating from CSFB

The Manulife Financial Corp. (MFC) Receives Outperform Rating from CSFB

Manulife Financial Corp. (TSE:MFC) (NYSE:MFC)‘s stock had its “outperform” rating reaffirmed by equities researchers at CSFB in a research note issued on Tuesday. They currently have a C$21.00 price objective on the stock. CSFB’s price target would suggest a potential downside of 9.33% from the stock’s current price. A number of other research firms have also recently weighed in on MFC. Dundee Securities reaffirmed a “buy” rating and issued a C$22.00 price objective on shares of Manulife Financial Corp. in a report on Wednesday, September 21st. Scotiabank cut their price…

The Corbus Pharmaceuticals Holdings Inc. (CRBP) Stock Rating Reaffirm by Aegis

The Corbus Pharmaceuticals Holdings Inc. (CRBP) Stock Rating Reaffirm by Aegis

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)‘s stock had its “buy” rating reiterated by stock analysts at Aegis in a report issued on Monday. Several other brokerages have also weighed in on CRBP. Cantor Fitzgerald reissued a “buy” rating and issued a $17.00 price objective on shares of Corbus Pharmaceuticals Holdings in a research report on Wednesday, October 26th. Noble Financial reissued a “buy” rating and issued a $19.00 price objective on shares of Corbus Pharmaceuticals Holdings in a research report on Friday. Shares of Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) traded down 4.237%…

The Ring Energy (REI) Receives “Buy” Rating from Canaccord Genuity

The Ring Energy (REI) Receives “Buy” Rating from Canaccord Genuity

Canaccord Genuity reissued their buy rating on shares of Ring Energy (NYSE:REI) in a report published on Monday morning. Canaccord Genuity currently has a $14.00 target price on the stock. REI has been the topic of a number of other research reports. Imperial Capital began coverage on shares of Ring Energy in a research report on Tuesday, September 27th. They set an outperform rating and a $13.50 price objective on the stock. Robert W. Baird restated a neutral rating and set a $24.00 price objective on shares of Ring Energy…

The National Bank of Canada’s (NA) “Neutral” Rating Reaffirm at CSFB

The National Bank of Canada’s (NA) “Neutral” Rating Reaffirm at CSFB

National Bank of Canada (TSE:NA)‘s stock had its “neutral” rating reaffirmed by CSFB in a research note issued to investors on Tuesday. They presently have a C$51.00 target price on the stock. CSFB’s target price would indicate a potential upside of 6.36% from the company’s previous close. Other equities research analysts have also recently issued reports about the stock. CIBC raised their target price on shares of National Bank of Canada from C$45.00 to C$47.00 in a research report on Thursday, September 1st. BMO Capital Markets raised their target price…

The Paylocity Holding Corp. (PCTY) Receives Buy Rating from Deutsche Bank AG

The Paylocity Holding Corp. (PCTY) Receives Buy Rating from Deutsche Bank AG

Deutsche Bank AG reissued their buy rating on shares of Paylocity Holding Corp. (NASDAQ:PCTY) in a report published on Monday morning. They currently have a $55.00 price objective on the stock. A number of other equities research analysts have also recently commented on PCTY. First Analysis upgraded shares of Paylocity Holding Corp. from an equal weight rating to an overweight rating and set a $48.00 target price for the company in a research report on Friday, November 4th. JMP Securities raised their price objective on shares of Paylocity Holding Corp….

The AMC Networks’ (AMCX) “Sell” Rating Reaffirm at Albert Fried & Company

The AMC Networks’ (AMCX) “Sell” Rating Reaffirm at Albert Fried & Company

Albert Fried & Company reaffirmed their sell rating on shares of AMC Networks Inc. (NASDAQ:AMCX) in a research report released on Monday morning. The brokerage currently has a $37.00 target price on the stock. AMCX has been the topic of a number of other research reports. Jefferies Group reaffirmed a hold rating on shares of AMC Networks in a research report on Monday, September 12th. Zacks Investment Research cut shares of AMC Networks from a hold rating to a sell rating in a research note on Monday, October 10th. Guggenheim…

The Square Inc. (SQ) Upgrade to Overweight at KeyCorp

The Square Inc. (SQ) Upgrade to Overweight at KeyCorp

KeyCorp upgraded shares of Square Inc. (NYSE:SQ) from a sector weight rating to an overweight rating in a research report released on Monday morning. SQ has been the subject of a number of other reports. Jefferies Group reissued a buy rating and set a $15.00 target price on shares of Square in a research report on Wednesday, September 28th. Vetr downgraded shares of Square from a strong-buy rating to a buy rating and set a $12.28 target price for the company. in a research report on Monday, October 3rd. Zacks…

The Old Dominion Freight Line’s (ODFL) Top Pick Rating Reaffirm at Deutsche Bank AG

The Old Dominion Freight Line’s (ODFL) Top Pick Rating Reaffirm at Deutsche Bank AG

Deutsche Bank AG reissued their top pick rating on shares of Old Dominion Freight Line Inc. (NASDAQ:ODFL) in a research report report published on Monday morning. Deutsche Bank AG currently has a $90.00 target price on the stock. A number of other equities research analysts have also recently commented on ODFL. Cowen and Company lifted their price target on shares of Old Dominion Freight Line from $63.00 to $73.00 and gave the stock a market perform rating in a report on Thursday, July 28th. Zacks Investment Research raised shares of…

The KB Home (KBH) Given a $15.00 Price Target by MKM Partners Analysts

The KB Home (KBH) Given a $15.00 Price Target by MKM Partners Analysts

MKM Partners set a $15.00 price objective on KB Home (NYSE:KBH) in a research report sent to investors on Monday morning. The brokerage currently has a a hold rating on the stock. Other analysts have also recently issued research reports about the company. Bank of America Corp. restated a sell rating and issued a $12.50 price target on shares of KB Home in a report on Wednesday, September 21st. Argus restated a hold rating on shares of KB Home in a report on Monday, July 18th. Zacks Investment Research cut…

The TransAlta Corp. (TAC) – Research Analysts’ Recent Ratings Updates

The TransAlta Corp. (TAC) – Research Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for TransAlta Corp. (NYSE: TAC): Shares of TransAlta Corp. (NYSE:TAC) traded up 1.974% during mid-day trading on Tuesday, hitting $3.875. 25,992 shares of the company’s stock were exchanged. The company has a market capitalization of $1.12 billion, a price-to-earnings ratio of 30.273 and a beta of 0.59. TransAlta Corp. has a 52 week low of $2.54 and a 52 week high of $5.62. The firm has a 50 day moving average price of $4.40 and a 200-day moving…

The Salesforce.com Inc. (CRM) Given a $95.00 Price Target at Cowen and Company

The Salesforce.com Inc. (CRM) Given a $95.00 Price Target at Cowen and Company

Cowen and Company set a $95.00 target price on Salesforce.com Inc. (NYSE:CRM) in a research report report published on Monday. The firm currently has a a buy rating on the CRM provider’s stock. Other research analysts have also recently issued research reports about the company. Citigroup Inc. dropped their price target on Salesforce.com from $97.00 to $94.00 and set a buy rating for the company in a research report on Wednesday, July 20th. Vetr upgraded Salesforce.com from a hold rating to a buy rating and set a $83.92 price objective…

The Mizuho Trust & Banking Co. Ltd. invests in Varian Medical Systems Inc. (VAR) Shares

The Mizuho Trust & Banking Co. Ltd. invests in Varian Medical Systems Inc. (VAR) Shares

Mizuho Trust & Banking Co. Ltd. increased its stake in Varian Medical Systems Inc. (NYSE:VAR) by 11.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 189,505 shares of the company’s stock after buying an additional 19,355 shares during the period. Mizuho Trust & Banking Co. Ltd. owned about 0.20% of Varian Medical Systems worth $18,861,000 at the end of the most recent quarter. Other hedge funds also recently added to or reduced their stakes in the company. Feltz Wealth…

The Mizuho Trust & Banking Co. Ltd. Cuts Stake in L-3 Communications Holdings Inc. (LLL)

The Mizuho Trust & Banking Co. Ltd. Cuts Stake in L-3 Communications Holdings Inc. (LLL)

Mizuho Trust & Banking Co. Ltd. reduced its position in shares of L-3 Communications Holdings Inc. (NYSE:LLL) by 0.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 126,155 shares of the company’s stock after selling 85 shares during the period. Mizuho Trust & Banking Co. Ltd. owned approximately 0.16% of L-3 Communications Holdings worth $19,015,000 at the end of the most recent reporting period. Several other large investors have also recently made changes to their positions in…

The Just Energy Group Inc. (JE) Given a $8.00 Price Target by FBR & Co Analysts

The Just Energy Group Inc. (JE) Given a $8.00 Price Target by FBR & Co Analysts

FBR & Co set a $8.00 price objective on Just Energy Group Inc. (NYSE:JE) in a research report released on Monday. The firm currently has a a buy rating on the stock. A number of other brokerages have also weighed in on JE. RBC Capital Markets restated a sector perform rating and set a $8.00 price objective (down previously from $8.50) on shares of Just Energy Group in a research report on Friday. TD Securities restated a hold rating and set a $8.50 price objective on shares of Just Energy…

The Mizuho Trust & Banking Co. Ltd. Raises Stake in Whirlpool Corp. (WHR)

The Mizuho Trust & Banking Co. Ltd. Raises Stake in Whirlpool Corp. (WHR)

Mizuho Trust & Banking Co. Ltd. increased its stake in Whirlpool Corp. (NYSE:WHR) by 0.6% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 120,962 shares of the company’s stock after buying an additional 695 shares during the period. Mizuho Trust & Banking Co. Ltd. owned 0.16% of Whirlpool Corp. worth $19,615,000 as of its most recent SEC filing. A number of other large investors also recently modified their holdings of WHR. Raymond James Trust N.A. boosted its stake in shares…

The Regions Financial Corp. (RF) Stake Boosted by Mizuho Trust & Banking Co. Ltd.

The Regions Financial Corp. (RF) Stake Boosted by Mizuho Trust & Banking Co. Ltd.

Mizuho Trust & Banking Co. Ltd. raised its stake in Regions Financial Corp. (NYSE:RF) by 0.5% during the third quarter, according to its most recent disclosure with the SEC. The firm owned 2,047,159 shares of the company’s stock after buying an additional 10,856 shares during the period. Mizuho Trust & Banking Co. Ltd. owned approximately 0.17% of Regions Financial Corp. worth $20,205,000 as of its most recent SEC filing. Several other hedge funds and other institutional investors have also added to or reduced their stakes in RF. Samlyn Capital LLC…

The JPMorgan Chase & Co. Reiterates Overweight Rating for Ciena Corp. (CIEN)

The JPMorgan Chase & Co. Reiterates Overweight Rating for Ciena Corp. (CIEN)

Ciena Corp. (NYSE:CIEN)‘s stock had its “overweight” rating reissued by analysts at JPMorgan Chase & Co. in a research note issued on Tuesday. Several other equities research analysts have also weighed in on CIEN. MKM Partners restated a “buy” rating and issued a $26.00 target price on shares of Ciena Corp. in a report on Tuesday, August 23rd. Citigroup Inc. boosted their target price on Ciena Corp. from $21.00 to $23.00 and gave the stock a “hold” rating in a report on Thursday, August 25th. Deutsche Bank AG upped their…

The Twitter Inc. (TWTR) Earns “Neutral” Rating from MKM Partners

The Twitter Inc. (TWTR) Earns “Neutral” Rating from MKM Partners

Twitter Inc. (NYSE:TWTR)‘s stock had its “neutral” rating restated by equities research analysts at MKM Partners in a report issued on Tuesday. They presently have a $18.50 target price on the social networking company’s stock. MKM Partners’ price objective suggests a potential downside of 3.34% from the company’s current price. A number of other research analysts also recently issued reports on TWTR. Nomura reissued a “neutral” rating and issued a $13.00 price objective on shares of Twitter in a research note on Monday, October 31st. Pacific Crest reaffirmed a “hold”…

The Nutanix’s (NTNX) Outperform Rating Reaffirm at Credit Suisse Group AG

The Nutanix’s (NTNX) Outperform Rating Reaffirm at Credit Suisse Group AG

Nutanix Inc (NASDAQ:NTNX)‘s stock had its “outperform” rating reiterated by equities research analysts at Credit Suisse Group AG in a research note issued on Tuesday. They presently have a $38.00 price target on the stock. Credit Suisse Group AG’s price target would indicate a potential upside of 34.75% from the stock’s previous close. A number of other equities analysts also recently issued reports on NTNX. Maxim Group initiated coverage on shares of Nutanix in a report on Friday, September 30th. They issued a “buy” rating and a $40.00 price target…

The Scotiabank Reaffirmed Sector Perform Rating for H&R Real Estate Investment Trust (HR.UN)

The Scotiabank Reaffirmed Sector Perform Rating for H&R Real Estate Investment Trust (HR.UN)

H&R Real Estate Investment Trust (TSE:HR.UN)‘s stock had its “sector perform” rating restated by equities research analysts at Scotiabank in a research note issued on Tuesday. They currently have a C$24.75 price target on the real estate investment trust’s stock. Several other analysts also recently issued reports on the company. BMO Capital Markets restated an “outperform” rating and set a C$26.00 price objective on shares of H&R Real Estate Investment Trust in a report on Monday, August 15th. TD Securities boosted their price objective on H&R Real Estate Investment Trust…

The HNZ Group Inc (HNZ) Price Target Decreased to C$13.50 at TD Securities

The HNZ Group Inc (HNZ) Price Target Decreased to C$13.50 at TD Securities

HNZ Group Inc (TSE:HNZ) had its target price dropped by equities researchers at TD Securities from C$16.50 to C$13.50 in a report released on Tuesday. The brokerage currently has a “hold” rating on the stock. TD Securities’ price target would indicate a potential upside of 22.50% from the company’s current price. Separately, Desjardins increased their price target on shares of HNZ Group from C$15.00 to C$16.00 and gave the stock a “buy” rating in a research note on Tuesday, August 16th. Shares of HNZ Group (TSE:HNZ) traded down 1.91% during…

The Nutanix Inc (NTNX) Rating Reiterate by Credit Suisse Group AG

The Nutanix Inc (NTNX) Rating Reiterate by Credit Suisse Group AG

Nutanix Inc (NASDAQ:NTNX)‘s stock had its “outperform” rating reaffirmed by equities researchers at Credit Suisse Group AG in a report released on Tuesday. They currently have a $38.00 price target on the stock. Credit Suisse Group AG’s target price would suggest a potential upside of 34.75% from the stock’s previous close. Other research analysts have also issued research reports about the company. Maxim Group started coverage on Nutanix in a research report on Friday, September 30th. They set a “buy” rating and a $40.00 price target on the stock. Needham…

The MKM Partners Reiterates “Neutral” Rating for Twitter Inc. (TWTR)

The MKM Partners Reiterates “Neutral” Rating for Twitter Inc. (TWTR)

Twitter Inc. (NYSE:TWTR)‘s stock had its “neutral” rating reiterated by equities researchers at MKM Partners in a research note issued on Tuesday. They currently have a $18.50 target price on the social networking company’s stock. MKM Partners’ price target would indicate a potential downside of 3.34% from the stock’s previous close. Several other research analysts have also recently commented on the stock. Vetr cut shares of Twitter from a “strong-buy” rating to a “buy” rating and set a $20.52 target price on the stock. in a report on Monday, July…

The Mizuho Trust & Banking Co. Ltd. Purchases 6,200 Shares of Ctrip.com International Ltd. (CTRP)

The Mizuho Trust & Banking Co. Ltd. Purchases 6,200 Shares of Ctrip.com International Ltd. (CTRP)

Mizuho Trust & Banking Co. Ltd. raised its position in shares of Ctrip.com International Ltd. (NASDAQ:CTRP) by 1.4% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 439,000 shares of the company’s stock after buying an additional 6,200 shares during the period. Mizuho Trust & Banking Co. Ltd. owned about 0.09% of Ctrip.com International worth $20,444,000 at the end of the most recent quarter. Several other institutional investors have also made changes to their positions in CTRP. Baillie Gifford & Co. boosted…

The Mizuho Trust & Banking Co. Ltd. Purchases 22,691 Shares of McCormick & Co. (MKC)

The Mizuho Trust & Banking Co. Ltd. Purchases 22,691 Shares of McCormick & Co. (MKC)

Mizuho Trust & Banking Co. Ltd. raised its stake in McCormick & Co. (NYSE:MKC) by 12.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 205,468 shares of the company’s stock after buying an additional 22,691 shares during the period. Mizuho Trust & Banking Co. Ltd. owned 0.16% of McCormick & Co. worth $20,530,000 at the end of the most recent reporting period. Other hedge funds and other institutional investors have also added to or reduced their stakes in…

The Mizuho Trust & Banking Co. Ltd. invests in Ralph Lauren Corp. (RL) Shares

The Mizuho Trust & Banking Co. Ltd. invests in Ralph Lauren Corp. (RL) Shares

Mizuho Trust & Banking Co. Ltd. boosted its stake in Ralph Lauren Corp. (NYSE:RL) by 0.0% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 204,503 shares of the company’s stock after buying an additional 97 shares during the period. Mizuho Trust & Banking Co. Ltd. owned approximately 0.25% of Ralph Lauren Corp. worth $20,683,000 at the end of the most recent reporting period. Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in…

The Galectin Therapeutics Inc. (GALT) Given a $2.00 Price Target at FBR & Co

The Galectin Therapeutics Inc. (GALT) Given a $2.00 Price Target at FBR & Co

FBR & Co set a $2.00 target price on Galectin Therapeutics Inc. (NASDAQ:GALT) in a research report sent to investors on Monday morning. The brokerage currently has a a hold rating on the stock. Other equities analysts have also issued reports about the stock. Roth Capital restated a sell rating and issued a $0.75 price objective (down from $3.00) on shares of Galectin Therapeutics in a research report on Wednesday, September 28th. HC Wainwright restated a buy rating and issued a $8.00 price objective on shares of Galectin Therapeutics in…

The JPMorgan Chase & Co. (JPM) Decreased to “Hold” at Zacks Investment Research

The JPMorgan Chase & Co. (JPM) Decreased to “Hold” at Zacks Investment Research

JPMorgan Chase & Co. (NYSE:JPM) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday. According to Zacks, “JPMorgan's third-quarter 2016 earnings handily outpaced the Zacks Consensus Estimate, driven by improved trading revenues, higher mortgage banking fees, growth in investment banking income and a rise in net interest income. Further, lower operating expenses aided the bottom-line growth. However, rise in provisions marginally hurt the results. The company is expected to continue witnessing a rise in interest income driven by solid…

The Alexion Pharmaceuticals Inc. (ALXN) Given a $176.00 Price Target by Piper Jaffray Cos. Analysts

The Alexion Pharmaceuticals Inc. (ALXN) Given a $176.00 Price Target by Piper Jaffray Cos. Analysts

Piper Jaffray Cos. set a $176.00 target price on Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) in a research note released on Monday morning. The brokerage currently has a a buy rating on the biopharmaceutical company’s stock. Several other brokerages also recently commented on ALXN. Wedbush lifted their target price on shares of Alexion Pharmaceuticals from $132.00 to $135.00 and gave the stock a neutral rating in a report on Friday, October 28th. Zacks Investment Research downgraded shares of Alexion Pharmaceuticals from a hold rating to a strong sell rating in a report…

The Equifax Inc. (EFX) Given Buy Rating at RBC Capital Markets

The Equifax Inc. (EFX) Given Buy Rating at RBC Capital Markets

RBC Capital Markets restated their buy rating on shares of Equifax Inc. (NYSE:EFX) in a research report sent to investors on Monday. Other analysts have also issued research reports about the stock. Zacks Investment Research raised shares of Equifax from a hold rating to a buy rating and set a $137.00 price objective for the company in a report on Monday, October 31st. Deutsche Bank AG set a $145.00 price objective on shares of Equifax and gave the stock a buy rating in a report on Tuesday, October 18th. Stifel…

The Puma Biotechnology Inc. (PBYI) Given a $88.00 Price Target by Citigroup Inc. Analysts

The Puma Biotechnology Inc. (PBYI) Given a $88.00 Price Target by Citigroup Inc. Analysts

Citigroup Inc. set a $88.00 price target on Puma Biotechnology Inc. (NYSE:PBYI) in a research report sent to investors on Monday. The brokerage currently has a a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently weighed in on PBYI. Stifel Nicolaus reissued a buy rating and issued a $88.00 price target on shares of Puma Biotechnology in a report on Thursday, November 10th. JPMorgan Chase & Co. set a $89.00 target price on Puma Biotechnology and gave the stock a buy rating in a…

The Ziopharm Oncology Inc. (ZIOP) gets Sell status at Zacks Investment Research

The Ziopharm Oncology Inc. (ZIOP) gets Sell status at Zacks Investment Research

Ziopharm Oncology Inc. (NASDAQ:ZIOP) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Tuesday. According to Zacks, “ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related molecules for better patient treatment. “ Several other…

The Identiv Inc. (INVE) Upgrade by Zacks Investment Research to Buy

The Identiv Inc. (INVE) Upgrade by Zacks Investment Research to Buy

Zacks Investment Research upgraded shares of Identiv Inc. (NASDAQ:INVE) from a hold rating to a buy rating in a report issued on Monday morning. The firm currently has $3.00 target price on the stock. According to Zacks, “Identiv Inc. is a global security technology company. It provides trust solutions in the connected world, including premises, information and everyday items. The Company’s trust solutions are implemented using standards-driven products and technology, such as hardware, software, digital certificates, and mobility and cloud services. Its products are used in corporate employee identification cards,…

The Analysts gives Consensus Recommendation of “Buy” to Five Below Inc. (FIVE)

The Analysts gives Consensus Recommendation of “Buy” to Five Below Inc. (FIVE)

Shares of Five Below Inc. (NASDAQ:FIVE) have been given a consensus recommendation of “Buy” by the twenty brokerages that are presently covering the company. Seven research analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $48.27. FIVE has been the subject of a number of recent research reports. MKM Partners restated a “buy” rating and set a $60.00 price objective…

The Barratt Developments Plc (BDEV) Receives Consensus Rating of “Hold” from Brokerages

The Barratt Developments Plc (BDEV) Receives Consensus Rating of “Hold” from Brokerages

Barratt Developments Plc (LON:BDEV) has been given an average recommendation of “Hold” by the fifteen analysts that are currently covering the company. Eleven investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is GBX 545.32 ($6.81). A number of research analysts have recently weighed in on the stock. JPMorgan Chase & Co. reissued a “neutral” rating and set a GBX 470…

The Abercrombie & Fitch Co. (ANF) Decreased to “Peer Perform” at Wolfe Research

The Abercrombie & Fitch Co. (ANF) Decreased to “Peer Perform” at Wolfe Research

Wolfe Research downgraded shares of Abercrombie & Fitch Co. (NYSE:ANF) from an outperform rating to a peer perform rating in a research report released on Monday morning. ANF has been the subject of several other research reports. Mizuho cut their price target on Abercrombie & Fitch Co. from $21.00 to $19.00 and set a neutral rating for the company in a report on Thursday, August 25th. Vetr raised Abercrombie & Fitch Co. from a buy rating to a strong-buy rating and set a $19.36 price objective for the company in…

The FY2019 EPS Estimates for Infinity Pharmaceuticals Inc. Increased by FBR & Co (INFI)

The FY2019 EPS Estimates for Infinity Pharmaceuticals Inc. Increased by FBR & Co (INFI)

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) – FBR & Co boosted their FY2019 earnings per share (EPS) estimates for Infinity Pharmaceuticals in a note issued to investors on Thursday. FBR & Co analyst C. James now forecasts that the brokerage will post earnings of $0.39 per share for the year, up from their prior forecast of $0.34. FBR & Co has a “Hold” rating on the stock. FBR & Co also issued estimates for Infinity Pharmaceuticals’ FY2020 earnings at $0.77 EPS. Other analysts also recently issued research reports about the stock. Wedbush…

The D.R. Horton Inc. to Post FY2019 Earnings of $2.83 Per Share, Keefe, Bruyette & Woods Forecasts (DHI)

The D.R. Horton Inc. to Post FY2019 Earnings of $2.83 Per Share, Keefe, Bruyette & Woods Forecasts (DHI)

D.R. Horton Inc. (NYSE:DHI) – Research analysts at Keefe, Bruyette & Woods issued their FY2019 earnings estimates for D.R. Horton in a research note issued on Wednesday. Keefe, Bruyette & Woods analyst J. Rahmani forecasts that the brokerage will earn $2.83 per share for the year. D.R. Horton (NYSE:DHI) last posted its earnings results on Tuesday, November 8th. The company reported $0.75 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.77 by $0.02. D.R. Horton had a return on equity of 13.93% and a net margin…

The American Eagle Outfitters Inc. (AEO) Decreased to Peer Perform at Wolfe Research

The American Eagle Outfitters Inc. (AEO) Decreased to Peer Perform at Wolfe Research

Wolfe Research cut shares of American Eagle Outfitters Inc. (NYSE:AEO) from an outperform rating to a peer perform rating in a report released on Monday morning. AEO has been the topic of a number of other reports. Zacks Investment Research raised shares of American Eagle Outfitters from a hold rating to a buy rating and set a $21.00 target price on the stock in a research note on Friday, August 19th. Deutsche Bank AG raised shares of American Eagle Outfitters from a hold rating to a buy rating and boosted…

The Brokers Issue Forecasts for Sage Therapeutics Inc.’s FY2020 Earnings (SAGE)

The Brokers Issue Forecasts for Sage Therapeutics Inc.’s FY2020 Earnings (SAGE)

Sage Therapeutics Inc. (NASDAQ:SAGE) – Investment analysts at Leerink Swann issued their FY2020 earnings per share (EPS) estimates for shares of Sage Therapeutics in a research note issued on Thursday. Leerink Swann analyst P. Matteis forecasts that the brokerage will earn $2.21 per share for the year. Leerink Swann has a “Outperform” rating and a $68.00 price objective on the stock. Sage Therapeutics (NASDAQ:SAGE) last issued its earnings results on Thursday, November 3rd. The biopharmaceutical company reported ($1.15) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate…

The Elliott Associates, LP Declares Ownership of 9.1% Stake in Arconic (ARNC)

The Elliott Associates, LP Declares Ownership of 9.1% Stake in Arconic (ARNC)

Elliott Associates, LP recently disclosed that they own 9.1% of Arconic (NASDAQ:ARNC) in a Form 13D/A disclosure that was filed with the SEC on Tuesday, November 15th. The investor owns 39,696,942 shares of the stock valued at approximately $757,814,623. The reporting parties listed on the disclosure included Elliott Associates, LP, Elliott International, LP and Elliott International Capital Advisors Inc. The disclosure is available through the SEC website at this link. Shares of Arconic (NASDAQ:ARNC) traded up 2.25% during trading on Tuesday, reaching $19.52. The company’s stock had a trading volume…

The Aegon NV (AEG) Given a $5.00 Price Target by Bank of America Corp. Analysts

The Aegon NV (AEG) Given a $5.00 Price Target by Bank of America Corp. Analysts

Bank of America Corp. set a $5.00 target price on Aegon NV (NYSE:AEG) in a report released on Monday morning. The firm currently has a a hold rating on the stock. A number of other equities analysts also recently commented on the stock. Zacks Investment Research downgraded shares of Aegon NV from a hold rating to a sell rating in a research note on Friday, November 4th. Societe Generale downgraded shares of Aegon NV from a buy rating to a hold rating in a research note on Wednesday, October 12th….

The Marc Stad Maintains 27.4% Stake in AppFolio Inc. (APPF)

The Marc Stad Maintains 27.4% Stake in AppFolio Inc. (APPF)

Marc Stad recently disclosed that they own a 27.4% stake in AppFolio Inc. (NASDAQ:APPF) in a Schedule 13D/A disclosure that was filed with the Securities and Exchange Commission on Tuesday, November 15th. The investor owns 3,594,895 shares of the stock worth about $77,469,987. The reporting parties listed on the disclosure included Marc Stad, Dragoneer Investment Group, LLC, Dragoneer Apartment, LLC and Dragoneer Global Fund II, LP. The filing is available through Edgar at this hyperlink. Other hedge funds and other institutional investors have also bought and sold shares of the…